Results 61 to 70 of about 10,825 (234)

Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)—Readdressing the DReSS

open access: yes, 2022
Drug reaction with eosinophilia and systemic symptoms (DReSS), also known as drug-induced hypersensitivity syndrome (DiHS), is a severe, systemic, T cell mediated drug reaction with combinations of cutaneous, hematologic, and internal organ involvement ...
Roni P. Dodiuk-Gad   +5 more
core   +1 more source

Inflammation Unchecked: Concurrent Kawasaki Disease and Stevens‐Johnson Syndrome in an 18‐Month‐Old Child

open access: yes
Arthritis Care &Research, EarlyView.
Catherine Deffendall   +6 more
wiley   +1 more source

Association of Online Parent‐Child Interactions With Depressive Symptoms Among Middle‐Aged and Older Empty Nesters in China

open access: yesJournal of Clinical Psychology, EarlyView.
ABSTRACT Objective Depression is prevalent among empty nest older adults who do not live with their children. With rapid technological development, online interaction presents a new opportunity to improve older adults' mental health. However, the relationship of online parent‐child interaction with depressive symptoms among empty nesters remains under ...
Wing‐yin Leung, Peiyi Lu
wiley   +1 more source

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin

open access: yesJournal of Research in Pharmacy Practice, 2016
Drug reaction with eosinophilia and systemic symptom (DRESS) is a severe adverse drug-induced reaction with a prolonged latency period which is characterized by a variety of clinical manifestations, usually fever, rash, lymphadenopathy, eosinophilia, and
Jitendra Singh   +4 more
doaj   +1 more source

Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome [PDF]

open access: yes, 2020
Background: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a complex multisystemic severe drug hypersensitivity reaction whose diagnosis and management are troublesome. DRESS syndrome requires management by various specialists.
Rojas-Pérez-Esquerra, P   +25 more
core   +1 more source

A novel central line securement vest reduces line trauma and improves quality of life in patients with intestinal failure

open access: yesJPGN Reports, EarlyView.
Abstract Objective We sought to assess the impact of a novel central line securement vest on the rate of line complications (trauma, infections, and replacements), and measures of quality of life (QOL) in pediatric patients with intestinal failure. Methods We enrolled patients at a single tertiary pediatric center.
Ryan E. St. Pierre‐Hetz   +6 more
wiley   +1 more source

Brentuximab Vedotin‐Induced Rash Sparing CD30‐Positive Mycosis Fungoides Lesions

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Brentuximab vedotin (BV) is an effective treatment for CD30‐positive lymphomas, including mycosis fungoides (MF). However, its use can be associated with various cutaneous adverse effects, including rashes. This case describes a 60‐year‐old male with stage IIB MF who developed a drug‐induced erythematous rash after three infusions of BV ...
Isabel Hariri   +2 more
wiley   +1 more source

Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in Pulmonary Tuberculosis Patient with Type 2 Respiratory Failure and Sepsis

open access: yesInternational Journal of Mycobacteriology
While anti-tuberculosis drugs (ATDs) are essential for tuberculosis (TB) treatment, they can induce severe hypersensitivity reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Brigita Sanina Manullang   +1 more
doaj   +1 more source

A case of DRESS syndrome associated with carbamazepine treatment

open access: yes, 2018
Fever and rash associated in a wide clinical spectrum, drug rash with eosiophilia and systemic symptoms syndrome (DRESS) is a potentially life-threatening hypersensitivity reaction.
Basak Nur Akyildiz   +9 more
core   +1 more source

DRESS syndrome due to iodinated contrast media. A case report.

open access: yes, 2023
20.500.12530/87858The most frequent non-immediate reactions described with iodinated contrast media (ICM) are mild to moderate, however, some cases of patients with severe non-immediate reactions, such as drug eruption with eosinophilia and systemic ...
Zambrano Ibarra, G   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy